Search research articles
Contact Us
Filters
Showing results (21-30 of 49) with videos related to
Page
of 5
Sort By:
Human Molecular Genetics
|
May 16, 2019
Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation
Steven D Rhodes, Yongzheng He, Abbi Smith, et al.
Human Molecular Genetics
|
July 19, 2013
Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice
Richa Sharma, Xiaohua Wu, Steven D Rhodes, et al.
Pediatric Blood & Cancer
|
September 17, 2015
Preclinical Evidence for the Use of Sunitinib Malate in the Treatment of Plexiform Neurofibromas
Michael J Ferguson, Steven D Rhodes, Li Jiang, et al.
Stem Cell Investigation
|
July 1, 2016
Interleukin 8/KC enhances G-CSF induced hematopoietic stem/progenitor cell mobilization in Fancg deficient mice
Yan Li, Wen Xing, Yong-Zheng He, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
July 1, 2020
A molecular basis for neurofibroma-associated skeletal manifestations in NF1
Yun Ma, Andrea M Gross, Eva Dombi, et al.
Research Square
|
June 30, 2025
An induced pluripotent stem cell model of Schwann cell differentiation reveals NF2- related gene regulatory networks
Olivia Lazaro, Sihong Li, William Carter, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 29, 2015
Nf1 Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal Homeostasis
Steven D Rhodes, Hao Yang, Ruizhi Dong, et al.
The Journal of Investigative Dermatology
|
June 18, 2023
Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous Neurofibromas
Verena Staedtke, Piotr Topilko, Lu Q Le, et al.
Plos One
|
October 8, 2011
The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1
Xiaohua Wu, Shi Chen, Yongzheng He, et al.
Cancer Discovery
|
June 13, 2024
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group
Elliot Stieglitz, Alex G Lee, Steven P Angus, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 49) with videos related to
Sort By:
Page
of 5
Human Molecular Genetics
|
May 16, 2019
Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation
Steven D Rhodes, Yongzheng He, Abbi Smith, et al.
Human Molecular Genetics
|
July 19, 2013
Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice
Richa Sharma, Xiaohua Wu, Steven D Rhodes, et al.
Pediatric Blood & Cancer
|
September 17, 2015
Preclinical Evidence for the Use of Sunitinib Malate in the Treatment of Plexiform Neurofibromas
Michael J Ferguson, Steven D Rhodes, Li Jiang, et al.
Stem Cell Investigation
|
July 1, 2016
Interleukin 8/KC enhances G-CSF induced hematopoietic stem/progenitor cell mobilization in Fancg deficient mice
Yan Li, Wen Xing, Yong-Zheng He, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
July 1, 2020
A molecular basis for neurofibroma-associated skeletal manifestations in NF1
Yun Ma, Andrea M Gross, Eva Dombi, et al.
Research Square
|
June 30, 2025
An induced pluripotent stem cell model of Schwann cell differentiation reveals NF2- related gene regulatory networks
Olivia Lazaro, Sihong Li, William Carter, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 29, 2015
Nf1 Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal Homeostasis
Steven D Rhodes, Hao Yang, Ruizhi Dong, et al.
The Journal of Investigative Dermatology
|
June 18, 2023
Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous Neurofibromas
Verena Staedtke, Piotr Topilko, Lu Q Le, et al.
Plos One
|
October 8, 2011
The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1
Xiaohua Wu, Shi Chen, Yongzheng He, et al.
Cancer Discovery
|
June 13, 2024
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group
Elliot Stieglitz, Alex G Lee, Steven P Angus, et al.
Page
of 5